During the past decade, Hoag Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hoag Cancer Center" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Hoag Memorial Hospital Presbyterian" with 3 trials sponsored, "Lisata Therapeutics, Inc." with 3 trials sponsored, "Chiron Corporation" with 2 trials sponsored and "Favrille" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hoag Cancer Center" #1 collaborator was "Cancer Biotherapy Research Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hoag Cancer Center" are "Brain and Central Nervous System Tumors" (2 trials), "Colon Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Colorectal Carcinoma" (2 trials) and "Colorectal Neoplasms" (2 trials). Many other conditions were trialed in "Hoag Cancer Center" in a lesser frequency.

Most popular intervention types in "Hoag Cancer Center" are "Biological" (8 trials), "Drug" (8 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "hMN14 (labetuzumab)" (3 trials), "Recombinant Human Interleukin-2 and Rituximab" (2 trials), "rituximab" (2 trials), "sargramostim" (2 trials) and "therapeutic autologous dendritic cells" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hoag Cancer Center" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hoag Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hoag Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hoag Cancer Center, 5 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".